CAD 0.1
(-9.09%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 215.47 Thousand CAD | -4.71% |
2022 | 226.13 Thousand CAD | 260.7% |
2021 | 62.69 Thousand CAD | 204.11% |
2020 | 20.61 Thousand CAD | -11.79% |
2019 | 23.37 Thousand CAD | -19.06% |
2018 | 28.87 Thousand CAD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 23.22 Thousand CAD | -61.78% |
2024 Q1 | 60.76 Thousand CAD | -3.41% |
2024 Q3 | 51.23 Thousand CAD | 120.6% |
2023 FY | 215.47 Thousand CAD | -4.71% |
2023 Q4 | 62.9 Thousand CAD | -17.7% |
2023 Q2 | 24.3 Thousand CAD | -57.24% |
2023 Q1 | 56.83 Thousand CAD | -30.11% |
2023 Q3 | 76.43 Thousand CAD | 214.5% |
2022 Q4 | 81.32 Thousand CAD | 103.41% |
2022 Q3 | 39.97 Thousand CAD | -32.56% |
2022 Q2 | 59.27 Thousand CAD | 4.81% |
2022 Q1 | 56.55 Thousand CAD | 2878.15% |
2022 FY | 226.13 Thousand CAD | 260.7% |
2021 Q2 | 11.18 Thousand CAD | 0.0% |
2021 FY | 62.69 Thousand CAD | 204.11% |
2021 Q4 | 1899.00 CAD | -80.69% |
2021 Q3 | 9833.00 CAD | -12.06% |
2020 FY | 20.61 Thousand CAD | -11.79% |
2019 FY | 23.37 Thousand CAD | -19.06% |
2018 FY | 28.87 Thousand CAD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Biosenta Inc. | 1.51 Million CAD | 85.734% |